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Objectives:  To describe  the  pulmonary  CT  ﬁndings  in  patients  with  anti-ARS-antibody-positive  interstitial
lung  disease  (anti-ARS-ILD)
Methods: The  CT  ﬁndings  of  64 patients  with  anti-ARS-ILD  were  retrospectively  reviewed.  The  images
were  retrospectively  reviewed  independently  by 2 chest  radiologists,  and  the  ﬁnal  decision  on  the  CT
ﬁndings  was  made  by a third  chest  radiologist.
Results:  There  were  16 male  and  48  female  patients,  aged  54.2  ±  13.4  years.  Sixteen  patients  had  anti  Jo-1,
24  had  anti-EJ,  9 had  anti-PL-7,  7 had  anti-PL-12,  5  had  anti-KS,  and 3 had  anti-OJ  antibodies.  Overall,  63
patients  (98.4%)  had  CT ﬁndings  predominantly  in the  lower  lobe;  61  patients  (95.3%)  showed  peripheral
opacities,  and  47  patients  (73.4%)  showed  peribronchovascular  opacities.  Ground-glass  attenuation,  con-
solidation,  and reticulation  showed  similar  distribution  patterns.  Regarding  detailed  CT  ﬁndings,  89.1%
of  patients  had  lower  volume  loss,  76.6%  had  interlobular  septal  thickening,  and 67.2% had  thickening  of
bronchovascular  bundles.  The  ﬁnal  radiologic  diagnoses  were  as  follows:  inconsistent  with  usual  inter-
stitial pneumonia  (UIP)  in  63  patients  (98.4%),  which  included  nonspeciﬁc  interstitial  pneumonia  (NSIP)
in  35  patients  (55.6%),  organizing  pneumonia  (OP)  in 4  patients  (6.3%),  and  OP with ﬁbrosis  in  22 patients
(34.9%).
Conclusions:  The  characteristic  CT  ﬁndings  of  patients  with  anti-ARS-ILD  were  areas  of  ground-glass
attenuation  and  reticulation,  predominantly  distributed  as  lower  and  peribronchovascular  lesions,  which
is compatible  with  NSIP.  One-third  of patients  showed  OP with  ﬁbrosis.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Myositis has long been known as a connective tissue disease
hat is frequently associated with interstitial lung disease. Pleu-
al irregularities and prominent parenchymal interlobular septa,
round-glass attenuation, patchy consolidation, parenchymal
ands, irregular peribronchovascular thickening, and subpleural
ines have been commonly found on the chest computed tomog-
aphy (CT) [1,2]. Some cases also show honeycombing on CT [3].
Patients with myositis were recently subclassiﬁed according to
arious myositis-related antibodies, including antiaminoacyl-tRNA
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synthetase (ARS) antibodies, anti-MDA5 antibody, and anti-TIF1
antibody, by investigators using immunoprecipitation assays [4].
Both the clinical and imaging features of each subclass of myositis
can be different.
Antibodies against ARS, a family of cytoplasmic enzymes, have
been shown to be highly speciﬁc for polymyositis and dermato-
myositis (PM/DM) and strongly associated with interstitial lung dis-
eases (ILDs) [4–7]. Anti-ARS antibodies include antihistidyl- (anti-
Jo-1), antiglycyl- (anti-EJ), antithreonyl- (anti-PL-7), antialanyl-
(anti-PL-12), antiisoleucyl- (anti-OJ), antiasparaginyl- (anti-KS),
antiphenylalanyl- (anti-Zo), and antityrosyl-tRNA synthetases.
Several studies have reported on the clinical, radiologic, and
pathologic pulmonary manifestations of patients with anti-ARS-
antibody-positive (anti-ARS)-ILD. Anti-ARS-ILD was  not uncom-
mon  in patients with idiopathic interstitial pneumonias (IIPs) [8],
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Table 1
Patinet characteristics.
Age 54.2 ± 13.4
Sex Male 16 Female 48
Smoking history Yes 23 No 41
Symptoms Myositis 36
Arthritis 23
Mechanic’s hands 16
Fever 18
Raynaud’s phenominon 17
ILD 64
Anti-ARS antibodies Jo-1 16
EJ 24
PL-7 9
PL-12 7
OJ 3
KS 5
Diagnosis IIP 23 CTD 41
PM 9
DM 24
MCTD 2
DM + SSc 1
SSc 1
Sjs 1
RA 1
PM + Sjs + RA 1
SSc + RA + Sjs 1
IIP, idiopathic interstitial pneumonia; CTD, connection tissue disease; PM,
polymyositis; DM,  dermatomyositis; MCTD, mixed connective tissue disease; SSc,
systemic screrosis; Sjs, Sjögren syndrome; RA, rheumatoid arthritis.
Table 2
Frequencies of the various CT ﬁndings.
CT ﬁnding Number of patients 
Ground-glass attenuation 63/64 (98.4) −0.03
Air-space consolidation 31/64 (48.4) 0.69
Reticulation 43/64 (67.2) 0.48
Honeycombing 2/64 (3.1) 0.79
Subpleural sparing 21/64 (32.8) −0.10
Interlobular septal thickening 49/64 (76.6) 0.07
Thickening of bronchovascular bundles 43/64 (67.2) 0.13
Pleural thickening or irregularity 29/64 (45.3) 0.12
Nonseptal linear opacity 22/64 (34.4) 0.11
Subpleural curve-linear shadow 24/64 (37.5) 0.28
Cyst  9/64 (14.0) 0.23
Enphysema 14/64 (21.9) 0.47
Lower volume loss 57/64 (89.1) 0.48
Predominant overall anatomic distribution
Peripheral 61/64 (95.3) 0.14
Peribronchovascular 47/64 (73.4) 0.37
Diffuse 1/64 (1.6) −0.02
Random 1/64 (1.6) N.A.
Dependent 1/64 (1.6) N.A.
Overall zonal predominance
Lower 63/64 (98.4) 0.32
Diffuse or Random 1/64 (1.6) 1.00
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abnormalities in each of the zones, which included spared areas,
ground-glass attenuation with and without traction bronchiecta-
sis, air-space consolidation, honeycombing, intralobular reticular
opacities, and emphysema. The percentage of whole lung involvednd patients with anti-ARS-ILD had common clinical pulmonary
anifestations, regardless of the presence of PM/DM [9]. Patients
ith anti-ARS-ILD usually have a chronic clinical course, nonspe-
iﬁc interstitial pneumonia (NSIP) and/or organizing pneumonia
OP) patterns on pulmonary CT, and a good response to corticoste-
oid treatment [10,11].
However, the detailed CT ﬁndings of patients with anti-ARS-ILD
re still unknown. The aim of this study was to clarify and describe
he CT ﬁndings of patients with anti-ARS-ILD.adiology 85 (2016) 1421–1426
2. Patients and methods
2.1. Study population
Our institutional review boards approved this retrospective
study. We  reviewed the medical records in our database of all
the patients seen in 2 institutions, who  were identiﬁed with anti-
ARS-ILD during the previous 10 years. Anti-ARS-ILD patients were
identiﬁed using the following criteria: diagnosed with ILD on chest
CT; positive for anti-ARS antibody; and without any other disease
manifesting abnormalities on chest CT, including sarcoidosis, pul-
monary infection, lymphoproliferative disease, lung cancer, and
hypersensitivity lung disease. Anti-ARS antibody was  detected by
immunoprecipitation assays [4] or enzyme-linked immunosorbent
assays (ELISAs) [12].
2.2. Examination and assessment of high-resolution (HR) CT
scans
HRCT examination of patients with anti-ARS-ILD was performed
during the initial work-up. HRCT data acquisition was  obtained at
end inspiration with the patient in the supine position, using a vari-
ety of CT systems. The protocols consisted of 1- or 2-mm collimation
sections reconstructed using a high-spatial-frequency algorithm at
1- or 2-cm intervals. The images were read at window settings
appropriate for viewing the lung parenchyma (window level −600
to −700 Hounsﬁeld units [HU], window width 1200 to 1500 HU)
and the mediastinum (window level 400–500 HU, window width
20–40 HU).
The images were retrospectively reviewed independently by
2 chest radiologists with 15–27 years of experience. Final deci-
sions on the ﬁndings were reached by a third chest radiologist
with 15 years of experience. The radiologists were aware that the
patients had anti-ARS-ILD, but were blinded to any other clinical
ﬁndings or patient outcome. Radiologists identiﬁed and further
evaluated the CT ﬁndings, including the extent of spared areas,
as follows: ground-glass attenuation, air-space consolidation, hon-
eycombing, intralobular reticular opacities, emphysema, traction
bronchiectasis, and the presence of subpleural sparing and upper
lobe subpleural irregular lines. The deﬁnitions of these CT ﬁndings
were based on the literature, as follows: ground-glass attenuation
was deﬁned as hazy, increased attenuation that did not obscure the
underlying vessels, and was further characterized as with or with-
out traction bronchiectasis; air-space consolidation was  deﬁned
as homogeneous increase in pulmonary parenchymal attenuation;
honeycombing was  deﬁned as clustered cystic air spaces with well
deﬁned and thick walls, ranging from several millimeters to 1
centimeter, seen in the subpleural regions; intralobular reticular
opacities were deﬁned as irregular and randomized linear shad-
ows  separated by a few millimeters; traction bronchiectasis was
deﬁned as irregular bronchial dilatation within or around areas
with parenchymal abnormalities; subpleural sparing was deﬁned
as an area of relative sparing adjacent to the pleura in the presence
of ﬁbrotic changes in the lung ﬁeld; and upper lobe subpleural irreg-
ular lines were deﬁned as irregular lines adjacent to the pleura in
the upper lobes [13–15].
The extent of CT ﬁndings was evaluated separately for 6 pul-
monary zones (upper, middle, and lower in each side). The borders
between the upper, middle, and lower lung zones were divided
by the level of the tracheal carina and the inferior pulmonary vein,
respectively. The radiologists estimated the percentage of lung with
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aig. 1. Ground-glass attenuation. (a) Thin-section CT scan of the right lung in a 44-ye
hin-section CT scan of the right lung in a 50-year-old man  with ARS-ILD (KS) demo
egions.  (c) Thin-section CT scan of the left lung in a 50-year-old man with ARS-ILD
ith abnormalities was calculated by determining the mean of the
ercentages of involved lung in each lung zone.
Traction bronchiectasis was evaluated by summing the number
f pulmonary segments with traction bronchiectasis. Subpleural
paring and upper lobe subpleural irregular lines were evaluated
s absent or present. The radiologists also determined the predomi-
ant distribution of CT ﬁndings and whether or not the distribution
as asymmetric. The predominant distribution of ﬁndings was
lassiﬁed as lower, peripheral, or peribronchovascular. Asymmetri-
al distribution was assessed as asymmetric extent or progression.
The ﬁnal radiological diagnosis was based on the criteria of
he ATS/ERS/JRS/ALAT guidelines [16]. Findings inconsistent with
he usual interstitial pneumonia (UIP) pattern were classiﬁed as:
ig. 2. Airspace consolidation. (a) Thin-section CT scan of the right lung in a 43-year-old
eribronchovascular regions (black arrows). Areas with ground-glass attenuation are see
f  the right lung in a 66-year-old man  with ARS-ILD (Jo-1) presents areas of airspace con
ttenuation are also seen (white arrows). man  with ARS-ILD (EJ) shows areas with ground-glass attenuation in peripheri. (b)
es areas with ground-glass attenuation in both peripheral and peribronchovascular
epicts areas with ground-glass attenuation in peribronchovascular regions.
“any further pattern”. OP with ﬁbrosis was identiﬁed on the CT of
patients who showed regions of air-space consolidation bilaterally,
predominantly in the lower lung zones, and loss of volume.
2.3. Statistical analysis
Statistical analysis was  performed using statistical software
(SPSS 12.0J, 2003; SPSS Inc. Chicago, IL). Interobserver agree-
ment regarding the presence/absence of CT ﬁndings and overall
impression of the ﬁndings was analyzed by calculating the kappa
statistic [17] on the assessments made prior to agreement by con-
sensus. Interobserver agreement was classiﬁed as follows: poor
 woman  with ARS-ILD (EJ) shows areas of airspace consolidation in peripheral and
n around those of airspace consolidation (white arrows). (b) Thin-section CT scan
solidation in peripheral and peribronchovascular regions. Areas with ground-glass
1 al of Radiology 85 (2016) 1421–1426
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Table 3
Frequencies of each CT ﬁnding according to anatomic distribution.
CT ﬁndings Number of patients
Ground-glass attenuation
Central predominance 0/63
Peripheral predominance 56/63
Peribronchovascular predominance 32/63
Diffuse predominance 3/63
Random predominance 2/63
Dependent predominance 1/63
Air-space consolidation
Central predominance 0/31
Peripheral predominance 27/31
Peribronchovascular predominance 29/31
Diffuse predominance 0/31
Random predominance 0/31
Dependent predominance 2/31
Reticulation
Central predominance 0/43
Peripheral predominance 30/43
Peribronchovascular predominance 16/43
Diffuse predominance 0/43
Random predominance 0/43
Dependent predominance 0/43
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 = 0–0.20), fair ( = 0.21–0.40), moderate ( = 0.41–0.60), substan-
ial ( = 0.61–0.80), and almost perfect ( = 0.81–1.00).
. Results
Table 1 shows the characteristics of the patients included in the
tudy. There were 16 men  and 48 women, aged 54.2 ± 13.4 years
mean ± SD) (range 18–79 years). Twenty-three patients were cur-
ent smokers or former smokers. The following types of anti-ARS
ntibodies were detected: anti-Jo-1 in 16, anti-EJ in 24, anti-PL-7 in
, anti-PL-12 in 7, anti-OJ in 3, and anti-KS in 5 patients. The follow-
ng disorders were deﬁnitively diagnosed: 23 patients with IIP; and
1 with connective tissue disease (CTD) (36 patients with PM/DM
2 of these patients also had another CTD] and a few patients with
ixed connective- tissue disease [MCTD], scleroderma, Sjögren
yndrome, and rheumatoid arthritis). With regard to prognosis,
6 patients were alive, 5 patients were died, and 13 patients were
nknown. Regarding interpretations of CT ﬁndings, interobserver
greement for each of the CT abnormalities ranged from poor
o substantial ( = −0.10–0.79) (Table 2). Interobserver agreement
or predominant overall anatomic distribution and overall zonal
redominance ranged from poor to perfect ( = −0.02–1.00). Inter-
bserver agreement regarding the diagnosis of UIP based on the
riteria of the ATS/ERS/JRS/ALAT guidelines [16] was moderate, and
as substantial regarding the ﬁnal diagnosis.
The frequencies of the various CT ﬁndings are summarized in
able 2. All anti-ARS-ILD patients presented with bilateral abnor-
al  shadows; bilateral areas with ground-glass attenuation were
ound in 63 (98.4%) of 64 patients (Fig. 1); air-space consolidation
as found in 31 (48.4%) of 64 patients (Fig. 2); and reticulation
as found in 43 (67.2%) of 64 patients (Fig. 3). Honeycombing was
ound in 2 (3.1%) of 64 patients, interlobular septal thickening in
9 (76.6%) of 64 patients, thickening of bronchovascular bundles
n 43 (67.2%) of 64 patients, nonseptal linear opacity in 22 (34.4%)
f 64 patients, subpleural curve-linear shadow in 24 (37.5%) of 64
atients, and lower volume loss in 57 patients (89.1%) of 64 patients.The predominant overall anatomic distribution was peripheral
n 61 (95.3%) of 64 patients and peribronchovascular in 47 (73.4%).
he predominant overall zonal predominance was  lower in 63
atients (98.4%).
ig. 3. Reticular opacities. (a) Thin-section CT scan of the right lung in a 64-year-old wom
T  scan of the right lung in a 59-year-old man with ARS-ILD (Jo-1) demonstrates reticula
can  of the left lung in a 64-year-old woman with ARS-ILD (EJ) presents reticular opacitieThe frequencies of each CT ﬁnding according to anatomic
distribution are listed in Table 3. Ground-glass attenuation had
peripheral predominance in 56 (88.9%) of 63 patients, and peribron-
chovascular predominance in 32 (50.8%) of 63 patients. Air-space
consolidation had peripheral predominance in 27 (87.1%) of 31
patients, and peribronchovascular predominance in 29 (93.5%)
of 31 patients. Reticulation had peripheral predominance in 30
(69.8%) of 43 patients and peribronchovascular predominance in
16 (37.2%) of 43 patients.
Table 4 shows the ﬁnal radiologic diagnosis as follows: 1 (1.6%)
of 64 patients had UIP, no patient had possible UIP, and 63 (98.4%)
of 64 patients had inconsistent UIP. Of the 63 patients, 35 (55.6%)
had nonspeciﬁc interstitial pneumonia (NSIP), 4 (6.3%) had OP,
22 (34.9%) had OP with ﬁbrosis, and 2 (3.2%) were unclassiﬁable
(Fig. 4).
an with ARS-ILD (KS) shows reticular opacities in peripheral areas. (b) Thin-section
r opacities in both peripheral and peribronchovascular regions. (c) Thin-section CT
s in both peripheral and peribronchovascular areas.
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Fig. 4. Ragiologic diagnosis. OP with ﬁbrosis. (a) Thin-section CT scan of the right lung i
scan  of the right lung in a 72-year-old woman  with ARS-ILD (EJ) presents NSIP pattern. (c
demonstrates OP with ﬁbrosis pattern. (d) Thin-section CT scan of the right lung in a 66-y
Table 4
Final radiologic diagnosis.
CT pattern Number of patients
UIP pattern 1/64
Possible UIP pattern 0/64
Inconsistent UIP pattern 63/64
NSIP pattern 35/63
OP  pattern 4/63
Organized ALI/OP with ﬁbrosis pattern 22/63
Other/Cannot classify 2/63
U
n
IP, usual interstitial pneumonia; NSIP, non-usual interstitial pneumonia; OP, orga-
izing pneumonia; ALI, acute lung injury.n a 67-year-old woman with ARS-ILD (EJ) shows NSIP pattern. (b) Thin-section CT
) Thin-section CT scan of the left lung in a 56–year-old woman with ARS-ILD (Jo-1)
ear-old man with ARS-ILD (PL-12) depicts OP with ﬁbrosis pattern.
4. Discussion
In this study, we evaluated the chest CT images of 64 patients
with anti-ARS-ILD, and found the 3 following characteristic ﬁnd-
ings: 1) the distribution of opacities was predominantly lower lobe,
peripheral, and/or peribronchovascular, 2) only a few patients man-
ifested honeycombing, and 3) OP with ﬁbrosis was seen in one-third
of patients.
Regarding the distribution of opacities, both reticulation
and consolidation were likely to occur in lower and periph-
eral and/or peribronchovascular areas. Moreover, consolidation
occurred strongly in peribronchovascular areas. Air-space consoli-
dation on CT is a pathologic reﬂection of intraluminal organization,
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and  organising pneumonia? Eur. Respir. J 25 (6) (2005) 1128, author reply.
[22] J.L. Sauter, K.J. Butnor, Expanding the spectrum of pulmonary
histopathological manifestations of anti-synthetase syndrome:426 Y. Waseda et al. / European Journ
nd ground-glass attenuation is associated with lymphocytic inﬁl-
ration of alveolar septa [9]. Therefore, our ﬁndings indicate that
oth luminal organization and inﬁltrated alveolar septa occurred
n either the peripheral or peribronchovascular pulmonary regions.
Regarding the rare occurrence of honeycombing, although ﬁbro-
is in anti-ARS-ILD manifests as reticulation, it may  not progress to
oneycombing. Therefore, although we applied the IPF guidelines
o them, they almost enter either possible UIP or inconsistent UIP
attern.
Regarding the patients who had OP with ﬁbrosis, many patients
ith anti-ARS-ILD have been reported to have ﬁndings consis-
ent with OP with ﬁbrosis [7], and this pattern was  described
n the ATS/ERS/JRS/ALAT guidelines Therefore, we  interpreted OP
ith ﬁbrosis as a speciﬁc pattern. Characteristic CT ﬁndings are
egions of airspace consolidation bilaterally that show prominent
oss of volume, and distribution predominantly in the basal seg-
ents. Regarding the patients which have OP with ﬁbrosis, The
IP guidelines [18] describe a group of patients with a condition
hat exacerbates relatively quickly, is resistant to therapy, and has
T manifestations of reticulations inside the opacities of OP. Some
nvestigators have reported that some patients with OP on chest CT
ad poor outcomes [19–21]. In addition, there have been previous
eports that patients with antisynthetase syndrome often have this
attern [18,22].
In some patients with antisynthetase syndrome, there seems to
e a close association between CT manifestations of OP and acute
r subacute exacerbation, and the exacerbation due to tapering
he dosage of immunosuppressive agents and steroids. Therefore,
 large number of anti-ARS-ILD patients should be studied using
recise radiologic-pathologic correlations and by reviewing the
utcomes and course of the disease over time.
There were several limitations to this study. First, the  values
f the 2 radiologists were relatively low, possibly because the bias
n answer to the items of each observer was too strong, matching
ate of two people was high, but  values came out low calcu-
ation. Therefore, we decided to use a third observer to make the
nal decisions. Second, since this was a retrospective study, there
ere various time phases on chest CT at the time of their ﬁrst visit.
he patients were initially seen at the Department of Respiratory
edicine with a chief complaint of respiratory symptoms such as
hortness of breath and dry cough, or an abnormal shadow was
een on a conventional chest radiograph during evaluation for con-
ective tissue disease or during a routine medical examination. A
tudy that includes more patients can overcome this limitation.
hird, despite excluding patients with other diseases manifesting
ith chest CT abnormalities, we could not exclude environmental
actors, such as smoking and occupational hazards, associated with
hest CT abnormalities. There is a limit that changes in all of the
mages were described in ARS; however a study that includes more
atients can overcome this limitation.
In conclusion, the characteristic CT ﬁndings of patients with
nti-ARS-ILD were areas of ground-glass attenuation and reticula-
ion, predominantly distributed as lower and peribronchovascular
esions, which is compatible with ﬁbrosing NSIP. One-third of our
atients had CT ﬁndings of OP with ﬁbrosis.
ey points
. Antibodies against ARS have been shown to be highly speciﬁc
for polymyositis and dermatomyositis (PM/DM) and strongly
associated with interstitial lung diseases (ILD).. Anti-ARS-antibody-positive (anti-ARS)-ILD was  not uncommon
in patients with idiopathic interstitial pneumonias, and patients
with anti-ARS-ILD had common clinical pulmonary manifesta-
tions, regardless of the presence of PM/DM.adiology 85 (2016) 1421–1426
3. The characteristic computed tomography (CT) ﬁndings of
patients with anti-ARS-ILD were areas of ground-glass atten-
uation and reticulation, predominantly distributed as lower
and peribronchovascular lesions, which were compatible with
ﬁbrosing nonspeciﬁc interstitial pneumonia.
4. One-third of our patients with anti-ARS-ILD had CT ﬁndings of
organizing pneumonia with ﬁbrosis.
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